Breaking News Instant updates and real-time market news.

MOH

Molina Healthcare

$140.92

2.06 (1.48%)

, GWR

Genesee & Wyoming

$83.32

0.89 (1.08%)

10:27
10/12/18
10/12
10:27
10/12/18
10:27

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Molina Healthcare (MOH) downgraded to Hold from Buy at Jefferies with analyst David Windley citing valuation. 2. Genesee & Wyoming (GWR) downgraded to Neutral from Overweight at JPMorgan with analyst Brian Ossenbeck saying the stock is up 20% since the Q4 of 2017 earnings as management completed divesting the majority of the failed European acquisition and opportunistically repurchased 3% of the shares outstanding. 3. Oneok (OKE) downgraded to Equal Weight from Overweight at Barclays. 4. Alder Biopharmaceuticals (ALDR) downgraded to Neutral from Buy at Mizuho with analyst Difei Yang saying she sees limited catalysts between an anticipated biologics license application submission in Q1 of 2019 and commercial launch expected in 2020. 5. Veon (VEON) downgraded to Neutral from Buy at Goldman Sachs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

MOH

Molina Healthcare

$140.92

2.06 (1.48%)

GWR

Genesee & Wyoming

$83.32

0.89 (1.08%)

OKE

Oneok

$65.47

0.24 (0.37%)

ALDR

Alder Biopharmaceuticals

$13.18

-0.22 (-1.64%)

VEON

Veon

$2.73

-0.04 (-1.44%)

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

MOH Molina Healthcare
$140.92

2.06 (1.48%)

10/09/18
EVER
10/09/18
INITIATION
Target $158
EVER
In Line
Molina Healthcare initiated with an In Line at Evercore ISI
Evercore ISI initiated Molina Healthcare with an In Line and $158 price target.
10/12/18
JEFF
10/12/18
DOWNGRADE
JEFF
Hold
Molina Healthcare downgraded to Hold on valuation at Jefferies
Jefferies analyst David Windley downgraded Molina Healthcare (MOH) to Hold with an unchanged price target of $152. The downgrade is based mostly on valuation as the company has pulled forward "significant earnings power faster than expected" and appreciated 80% year-to-date, Windley tells investors in a research note. The analyst, however, remains constructive on Managed Care fundamentals with a bias to own diversified insurers. He likes we like UnitedHealth's (UNH) Q4 set-up and also believe Cigna's (CI) multiple can expand.
10/12/18
JEFF
10/12/18
DOWNGRADE
Target $152
JEFF
Hold
Molina Healthcare downgraded to Hold from Buy at Jefferies
Jefferies analyst David Windley downgraded Molina Healthcare to Hold with an unchanged price target of $152.
10/03/18
LEER
10/03/18
NO CHANGE
LEER
Upcoming midterm elections to act as key catalyst driving healthcare, says Leerink
Leerink analyst Ana Gupte expects the upcoming midterm elections to act as a key catalyst driving healthcare. This midterm has the potential for even more impact given the 2020 Presidential election could even lead to a Democratic supermajority, she contends. Gupte sees the most upside opportunity in Managed Medicaid stocks, such as Centene (CNC) and Molina Healthcare (MOH), and for Facilities names like HCA Healthcare (HCA) with a Blue Wave increasing Red state Medicaid expansions. Medicare Advantage with Humana (HUM) as the flagship name is her contrarian election pick. The analyst recommends buying Diversified MCOs with captive PBMs like UnitedHealth (UNH)/Optum [OP], Anthem (ANTM)/Ingenio Rx, and Cigna (CI)/Express Scripts (ESRX) under all scenarios.
GWR Genesee & Wyoming
$83.32

0.89 (1.08%)

08/09/18
08/09/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Seagate (STX) downgraded to Sell from Neutral at Goldman Sachs by analyst Mark Delaney, who said that while Seagate has improved its product offerings in the last few years, hard disk drives remain a cyclical industry, and one "facing secular challenges in many parts of the market." 2. 21st Century Fox (FOXA) downgraded to Sector Perform from Outperform at RBC Capital by analyst Steven Cahall who noted that the stock is now trading near its M&A price and that he does not see any competitive bids emerging. 3. e.l.f. Beauty (ELF) downgraded to Hold from Buy at Jefferies by analyst Stephanie Wissink, who said she is disappointed with the company's "sales fall off," which she says "seems more systemic than previously assumed." e.l.f.'s profit advancement will reverse in the second half of the year amid stepped up brand investment. Shares were also downgraded to Underweight from Neutral at Piper Jaffray, who said she sees a "growing risk of shelf-space cuts into 2019" if underlying sales trends do not improve, at Citi to Neutral from Buy and at DA Davidson to Neutral from Buy. 4. Southern Company (SO) downgraded to Underperform from In Line at Evercore ISI by analyst Greg Gordon, who said he believes the shares are still not discounting enough risk after the company announced a $790M after-tax charge related to an increase in the cost estimate for constructing Vogtle Nuclear Plants 3 and 4. Shares were also downgraded to Underperform from Neutral at Credit Suisse, to Equal Weight from Overweight at Barclays and to Neutral from Buy at Guggenheim. 5. Schneider National (SNDR) downgraded to Underperform from Buy at BofA/Merrill by analyst Ken Hoexter, who cited "stretched" relative valuation. The analyst also downgraded Genesee & Wyoming (GWR) to Neutral from Buy, saying recent strength in shares has led to a premium multiple and sees minimal upside. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/12/18
JPMS
10/12/18
DOWNGRADE
Target $95
JPMS
Neutral
Genesee & Wyoming downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Brian Ossenbeck downgraded Genesee & Wyoming to Neutral while raising his price target for the shares to $95 from $90.
10/12/18
JPMS
10/12/18
DOWNGRADE
JPMS
Neutral
Genesee & Wyoming downgraded to Neutral after rally at JPMorgan
JPMorgan analyst Brian Ossenbeck downgraded Genesee & Wyoming to Neutral from Overweight while raising his price target for the shares to $95 from $90. The stock is up 20% since the Q4 of 2017 earnings as management completed divesting the majority of the failed European acquisition and opportunistically repurchased 3% of the shares outstanding, Ossenbeck tells investors in a research note. The analyst sees a more balanced risk/reward following the recent run in the shares.
08/24/18
SPHN
08/24/18
NO CHANGE
SPHN
Overweight
Rail shipper survey indicates fundamentals remain positive, says Stephens
Stephens analyst Justin Long conducted a rail shipper survey to gauge expectations for both 2H18 and 2019, telling investors that, based on responses from shippers that collectively manage an estimated ~$20B of annual transportation spend, "it is clear that fundamentals in the rail sector remain positive." Long says key takeaways from the survey were that rail volumes are expected to be up 3%-4% over the next 18 months, rail price increases are accelerating to +4%-+5% and the rail service environment has transitioned to more adequate levels. While he believes investors will continue to weigh these positives against expanded valuation multiples and macro uncertainties Long maintains Overweight ratings on Genesee & Wyoming (GWR), CSX (CSX), Norfolk Southern (NSC) and Union Pacific (UNP).
OKE Oneok
$65.47

0.24 (0.37%)

08/02/18
WELS
08/02/18
NO CHANGE
Target $77
WELS
Outperform
Oneok price target raised to $77 from $69 at Wells Fargo
Wells Fargo analyst Michael Blum raised his price target for Oneok to $77 from $69 after the company reported Q2 results above his forecast, slightly raised the midpoint of its full-year guidance, and noted the possibility of hitting the high end of guidance this year. The analyst reiterates an Outperform rating on the shares.
10/12/18
LEHM
10/12/18
DOWNGRADE
Target $70
LEHM
Equal Weight
Oneok downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Christine Cho downgraded Oneok to Equal Weight and lowered her price target for the shares to $70 from $73.
10/08/18
GSCO
10/08/18
INITIATION
Target $68
GSCO
Neutral
Oneok initiated with a Neutral at Goldman Sachs
Price target $68.
10/10/18
FBCO
10/10/18
INITIATION
Target $74
FBCO
Neutral
Oneok initiated with a Neutral at Credit Suisse
Credit Suisse analyst Spiro Dounis initiated Oneok with a Neutral rating and a price target of $74.
ALDR Alder Biopharmaceuticals
$13.18

-0.22 (-1.64%)

09/10/18
09/10/18
INITIATION
Target $19

Underweight
Morgan Stanley starts Alder at Underweight given crowded migraine market
As previously reported, Morgan Stanley analyst Jeffrey Hung started Alder Biopharmaceuticals with an Underweight rating, noting that the company's migraine drug will be the fourth to market of the same class. Alder's drug has a fast onset, but he views efficacy across these drugs as largely similar, Hung tells investors. The consensus estimate of $750M for Alder's drug by 2025 needs to come down, according to the analyst, who set a $19 price target on the stock.
10/12/18
MZHO
10/12/18
DOWNGRADE
Target $15
MZHO
Neutral
Alder Biopharmaceuticals downgraded to Neutral from Buy at Mizuho
Mizuho analyst Difei Yang downgraded Alder Biopharmaceuticals to Neutral and lowered her price target for the shares to $15 from $29. The analyst sees limited catalysts between an anticipated biologics license application submission in Q1 of 2019 and commercial launch expected in 2020. Investors could remain on the sidelines and away from higher risk names given the current higher volatility in the market, Yang tells investors in a research note.
09/10/18
MSCO
09/10/18
INITIATION
MSCO
Underweight
Alder Biopharmaceuticals initiated with an Underweight at Morgan Stanley
08/22/18
CANT
08/22/18
INITIATION
Target $21
CANT
Neutral
Alder Biopharmaceuticals initiated with a Neutral at Cantor Fitzgerald
Cantor Fitzgerald analyst Charles Duncan initiated Alder Biopharmaceuticals with a Neutral and $21 price target.
VEON Veon
$2.73

-0.04 (-1.44%)

07/05/18
GSCO
07/05/18
UPGRADE
Target $4
GSCO
Buy
Veon upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Vyacheslav Degtyarev upgraded Veon to Buy from Neutral and raised his price target to $4.00 from $2.90. The analyst says the company's sale of a 50% stake in JV Wind Tre to Hutchison for EUR 2.45B "highlights management's willingness to create shareholder value through portfolio simplification". Degtyarev adds that despite the 13% rise in Veon stock price following the announcement, the current share price still does not reflect the management's commitment to a "strategic shift".
10/12/18
GSCO
10/12/18
DOWNGRADE
GSCO
Neutral
Veon downgraded to Neutral from Buy at Goldman Sachs
10/12/18
GSCO
10/12/18
INITIATION
Target $3.5
GSCO
Neutral
Veon reinstated with a Neutral at Goldman Sachs
Goldman Sachs analyst Vyacheslav Degtyarev reinstated a Neutral rating and $3.50 price target on Veon, down from the firm's previous Buy rating. In a research note to investors, the analyst cited Veon's balanced risk/reward profile and said he sees little risk to the company's progressive dividend policy following the completion of the sale of its 50% in its Italian JV. However, the analyst sees "limited" room for significant dividend growth given Veon's exposure to "challenging" operations with volatile currencies.
08/20/18
HSBC
08/20/18
UPGRADE
HSBC
Buy
Veon upgraded to Buy from Hold at HSBC

TODAY'S FREE FLY STORIES

SNX

Synnex

$80.46

1.84 (2.34%)

17:42
10/22/18
10/22
17:42
10/22/18
17:42
Hot Stocks
Synnex director Matthew Miau buys over $9.5M in company stock »

Synnex director Matthew…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

SMBC

Southern Missouri Bancorp

$36.25

0.03 (0.08%)

17:32
10/22/18
10/22
17:32
10/22/18
17:32
Earnings
Southern Missouri Bancorp reports Q3 EPS 76c, consensus 69c »

Reports Q3 provision for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMST

TimkenSteel

$12.19

-0.12 (-0.97%)

17:30
10/22/18
10/22
17:30
10/22/18
17:30
Hot Stocks
Breaking Hot Stocks news story on TimkenSteel »

Luminus Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

CEMI

Chembio Diagnostics

$9.68

-0.05 (-0.51%)

17:27
10/22/18
10/22
17:27
10/22/18
17:27
Syndicate
Chembio Diagnostics files to sell $25M of common stock »

Canaccord Genuity and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

SLM

Sallie Mae

$10.58

(0.00%)

17:23
10/22/18
10/22
17:23
10/22/18
17:23
Hot Stocks
Sallie Mae reports Q3 net interest margin up 15bps at 6.00% »

Q3 Private education loan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

SLM

Sallie Mae

$10.58

(0.00%)

17:22
10/22/18
10/22
17:22
10/22/18
17:22
Earnings
Sallie Mae raises FY18 core EPS view to $1.02-$1.03 from 99c-$1.01 »

Consensus$1.02. Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

SLM

Sallie Mae

$10.58

(0.00%)

17:19
10/22/18
10/22
17:19
10/22/18
17:19
Earnings
Sallie Mae reports Q3 adjusted EPS 23c, consensus 24c »

Reports Q3 NII $356.6M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

BA

Boeing

$355.98

-0.3 (-0.08%)

17:17
10/22/18
10/22
17:17
10/22/18
17:17
Hot Stocks
Correction: Boeing maintains quarterly dividend of $1.71 »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

JOE

Saint Joe Co.

$15.08

-0.14 (-0.92%)

, MAR

Marriott

$111.49

-0.58 (-0.52%)

17:15
10/22/18
10/22
17:15
10/22/18
17:15
Hot Stocks
St. Joe Company, InterMountain break ground on New Towneplace Suites Hotel »

The St. Joe Company (JOE)…

JOE

Saint Joe Co.

$15.08

-0.14 (-0.92%)

MAR

Marriott

$111.49

-0.58 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

RNST

Renasant

$35.44

-1.1 (-3.01%)

17:11
10/22/18
10/22
17:11
10/22/18
17:11
Earnings
Renasant reports Q3 adjusted EPS 61c, consensus 77c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Dec

IAG

IAMGold

$3.84

-0.13 (-3.27%)

17:09
10/22/18
10/22
17:09
10/22/18
17:09
Hot Stocks
IAMGold announces positive results from a feasibility study for Senegal project »

IAMGOLD announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

HWBK

Hawthorn Bancshares

$23.20

-0.27 (-1.15%)

17:09
10/22/18
10/22
17:09
10/22/18
17:09
Hot Stocks
Breaking Hot Stocks news story on Hawthorn Bancshares »

Endeavour Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNBC

Green Bancorp

$19.34

-0.7 (-3.49%)

17:07
10/22/18
10/22
17:07
10/22/18
17:07
Earnings
Green Bancorp reports Q3 EPS 49c, consensus 47c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

VBTX

Veritex

$24.43

-1.07 (-4.20%)

17:06
10/22/18
10/22
17:06
10/22/18
17:06
Earnings
Veritex reports Q3 core EPS 34c, consensus 46c »

Reports Q3 tangible book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

IBTX

Independent Bank

$56.47

-3.06 (-5.14%)

17:04
10/22/18
10/22
17:04
10/22/18
17:04
Earnings
Independent Bank reports Q3 EPS $1.20, consensus $1.20 »

Net interest income was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

BRO

Brown & Brown

$29.12

0.27 (0.94%)

17:03
10/22/18
10/22
17:03
10/22/18
17:03
Hot Stocks
Breaking Hot Stocks news story on Brown & Brown »

Brown & Brown reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 02

    Nov

  • 14

    Nov

SFNC

Simmons First National

$25.62

-0.78 (-2.95%)

17:03
10/22/18
10/22
17:03
10/22/18
17:03
Hot Stocks
Breaking Hot Stocks news story on Simmons First National »

Simmons First National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 26

    Nov

CR

Crane

$87.33

-0.28 (-0.32%)

17:03
10/22/18
10/22
17:03
10/22/18
17:03
Earnings
Crane raises FY18 EPS ex-items view to $5.80-$5.90 from $5.60-$5.80 »

Consensus $5.75. Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 05

    Dec

  • 06

    Dec

GNBC

Green Bancorp

$19.34

-0.7 (-3.49%)

17:02
10/22/18
10/22
17:02
10/22/18
17:02
Earnings
Green Bancorp reports Q3 non-GAAP EPS 49c, consensus 47c »

Reports Q3 provision for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

SFNC

Simmons First National

$25.62

-0.78 (-2.95%)

17:02
10/22/18
10/22
17:02
10/22/18
17:02
Earnings
Simmons First National reports Q3 core EPS 61c, consensus 58c »

Reports Q3 net interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 26

    Nov

CR

Crane

$87.33

-0.28 (-0.32%)

17:02
10/22/18
10/22
17:02
10/22/18
17:02
Earnings
Crane reports Q3 EPS ex-items $1.62, consensus $1.46 »

Reports Q3 revenue $856M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 05

    Dec

  • 06

    Dec

BRO

Brown & Brown

$29.12

0.27 (0.94%)

17:01
10/22/18
10/22
17:01
10/22/18
17:01
Earnings
Brown & Brown reports Q3 adjusted EPS 38c, consensus 34c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 02

    Nov

  • 14

    Nov

NBTB

NBT Bancorp

$36.29

-0.57 (-1.55%)

16:54
10/22/18
10/22
16:54
10/22/18
16:54
Hot Stocks
NBT Bancorp raises quarterly dividend to 26c from 25c per share »

The dividend will be paid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBTB

NBT Bancorp

$36.29

-0.57 (-1.55%)

16:54
10/22/18
10/22
16:54
10/22/18
16:54
Earnings
NBT Bancorp reports Q3 adjusted EPS 68c, consensus 65c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PERY

Perry Ellis

$27.50

(0.00%)

16:51
10/22/18
10/22
16:51
10/22/18
16:51
Hot Stocks
Perry Ellis announces completion of its acquisition in $437M transaction »

Perry Ellis International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.